Drug Trial Radar · NCT07101328
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
Last checked: Nov 20, 2026Latest source record: Nov 4, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
215
Planned (sponsor's estimate)
Start
May 28, 2026
Primary completion
Apr 2027
Study completion Sep 2029
Sponsor
- Lead sponsor
- Eli Lilly and CompanyEli Lilly (LLY)
- Sponsor type
- Industry
- First posted
- Aug 3, 2025
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Sequential
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to find the best dose of the drug and measure the safety and efficacy of LY4152199 in participants with previously treated B-cell malignancies. Participants will have the option to continue taking LY4152199 until the study ends.
Conditions
- Lymphoma, Non-Hodgkin
- B-cell Lymphoma
- Lymphoma, Large B-Cell, Diffuse
- Lymphoma, Follicular
- Lymphoma, B-cell Marginal Zone
- Waldenstrom Macroglobulinemia
- Lymphoma, Mantle Cell
Interventions
LY4152199 - IVDrug
Administered by IV infusion
Primary outcomes
What the sponsor says the trial is designed to measure.
- Phase 1 - Number of Participants with Dose Limiting Toxicities (DLT) of LY4152199Time frame: Cycle 1 Day 1 through Cycle 2 Day 8 (35 days)
Locations
51 sites in 12 countries. Site status is shown where the registry gives one.
City of Hope
Duarte, California · Recruiting
University of Colorado Denver - School of Medicine - Anschutz Medical Campus
Aurora, Colorado · Recruiting
Colorado Blood Cancer Institute
Denver, Colorado · Recruiting
Yale University School of Medicine - Yale Cancer Center
New Haven, Connecticut · Recruiting
The University of Chicago Medical Center (UCMC)
Chicago, Illinois · Recruiting
University of Iowa
Iowa City, Iowa · Recruiting
University of Kansas Cancer Center
Kansas City, Kansas · Recruiting
Massachusetts General Hospital
Boston, Massachusetts · Recruiting
Dana-Farber Cancer Institute
Boston, Massachusetts · Recruiting
University of Michigan Comprehensive Cancer Center
Ann Arbor, Michigan · Recruiting
Mayo Clinic - Rochester
Rochester, Minnesota · Recruiting
Rutgers Cancer Institute of New Jersey
New Brunswick, New Jersey · Not yet recruiting
New York University (NYU) Clinical Cancer Center
New York, New York · Recruiting
Weill Cornell Medicine
New York, New York · Recruiting
David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center
New York, New York · Recruiting
Cleveland Clinic
Cleveland, Ohio · Recruiting
University of Pennsylvania Abramson Cancer Center
Philadelphia, Pennsylvania · Recruiting
SCRI Oncology Partners
Nashville, Tennessee · Recruiting
University of Texas Southwestern
Dallas, Texas · Recruiting
MD Anderson Cancer Center
Houston, Texas · Recruiting
Intermountain Healthcare
Salt Lake City, Utah · Not yet recruiting
Swedish Cancer Institute (SCI)
Seattle, Washington · Recruiting
Froedtert Hospital and the Medical College of Wisconsin
Milwaukee, Wisconsin · Recruiting
The Alfred Hospital
Melbourne, VIC, Australia · Recruiting
Linear Clinical Research
Nedlands, Australia · Recruiting
Lady Davis Institute for Medical Research Jewish General Hospital
Montreal, Canada · Not yet recruiting
University Health Network (UHN) - Princess Margaret Cancer Centre
Toronto, Canada · Not yet recruiting
BC Cancer - Vancouver
Vancouver, Canada · Not yet recruiting
Aarhus University Hospital
Aarhus, Denmark · Not yet recruiting
Center for Cancer and Organ Diseases - Rigshospitalet
Copenhagen, Denmark · Not yet recruiting
CHU de Lille - Hopital Claude Huriez
Lille, France · Not yet recruiting
AP-HP Hopital Saint-Louis
Paris, France · Not yet recruiting
Charite Universitaetsmedizin Berlin
Berlin, Germany · Not yet recruiting
LMU Klinikum Muenchen-Campus Grosshadern
München, Germany · Not yet recruiting
Universitaetsklinikum Muenster
Münster, Germany · Not yet recruiting
IRCCS Azienda Ospedaliero-Universitaria di Bologna - Policlinico di Sant Orsola
Bologna, Italy · Not yet recruiting
Istituto Nazionale Tumori IRCCS Fondazione G. Pascale
Naples, Italy · Not yet recruiting
Istituto Clinico Humanitas
Rozzano, Italy · Not yet recruiting
National Cancer Center Hospital East
Chiba, Japan · Not yet recruiting
Okayama University Hospital
Okayama, Japan · Recruiting
Showing 40 of 51 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.